Neimeth International Pharmaceuticals Plc


Mkt Cap: ₦3.0b

Neimeth International Pharmaceuticals Past Performance

How has Neimeth International Pharmaceuticals performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NEIMETH is currently unprofitable.

Growing Profit Margin: NEIMETH is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: NEIMETH is unprofitable, but has reduced losses over the past 5 years at a rate of 1.3% per year.

Accelerating Growth: Unable to compare NEIMETH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NEIMETH is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (22.9%).

Return on Equity

High ROE: NEIMETH has a negative Return on Equity (-25.92%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies